Where Global Innovation
and Capital Meet
Sectors Art of CVCConsumerEnergyFinancialHealthIndustrialITMediaServicesStartupsTelecomsTransportUniversity

Page 387

Stratasys to print up to $100m for Origin

Stanford University has scored an exit after photosensitive polymer-based 3D printing business Origin agreed to a $100m acquisition.

Dec 14, 2020

AbCellera accomplishes $483m initial public offering

The Eli Lilly-backed antibody discovery platform developer's shares opened at more than three times their IPO price to net it a valuation topping $15bn.

Dec 14, 2020

Stratasys locates Origin for $100m acquisition

TDK Ventures has scored an exit after 3D printing technology developer Origin after Stratasys agreed to buy it in a deal that could reach $100m.

Dec 14, 2020

DataRobot updates series F to $320m

Snowflake, Hewlett Packard Enterprise and Salesforce Ventures helped the enterprise AI platform developer hit a $2.8bn valuation.

Dec 14, 2020

Uber drives $75m Joby Aviation investment

The ride hailing service has sold its Uber Elevate subsidiary to urban aircraft developer and portfolio company Joby alongside a new $75m investment.

Dec 14, 2020

Calm coalesces $75m into series C round

This latest funding round for the CAA-backed meditation app developer doubled its valuation to $2bn and brought its total funding to $217m.

Dec 14, 2020

Corporate venturing deal net: 7-11 December 2020

Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.

Dec 11, 2020

Daily deal net: December 11, 2020

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Dec 11, 2020

Squire squares $59m series C round

SoftBank Opportunity Fund has backed a debt and equity round that reportedly valued the hair appointment management platform at $250m.

Dec 11, 2020

Tempus amps up funding with $200m

Google and existing investor Novo contributed to a series G2 round valuing the precision medicine developer at $8.1bn post-money.

Dec 11, 2020
© 2026 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here